Clinical trial

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

NCT00423501

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention taspoglutide Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-02-01

PhasePHASE2

Conditions

Diabetes Mellitus Type 2unresolved

Interventions

PlaceboDRUG

taspoglutideDRUG

Sponsors & collaborators

Hoffmann-La Rochelead sponsor

Mapped research locations

Mexico CityMexico4 BucharestRomania3 SofiaBulgaria2 GuadalajaraMexico2 ChicagoIllinois, United States1 DallasTexas, United States1 San AntonioTexas, United States1 PortlandOregon, United States1 BerlinGermany1 Washington D.C.District of Columbia, United States1 RochesterNew York, United States1 RichmondVirginia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00423501 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.